Growth Metrics

Synopsys (SNPS) Cash & Equivalents (2016 - 2026)

Synopsys' Cash & Equivalents history spans 18 years, with the latest figure at $43.1 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 98.82% year-over-year to $43.1 million; the TTM value through Jan 2026 reached $43.1 million, down 98.82%, while the annual FY2025 figure was $2.9 billion, 25.92% down from the prior year.
  • Cash & Equivalents reached $43.1 million in Q1 2026 per SNPS's latest filing, down from $2.9 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $14.1 billion in Q2 2025 to a low of $43.1 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $2.5 billion, with a median of $1.6 billion recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 838.02% in 2025, then crashed 98.82% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $1.4 billion in 2022, then increased by 11.67% to $1.6 billion in 2023, then soared by 145.88% to $3.9 billion in 2024, then dropped by 25.92% to $2.9 billion in 2025, then plummeted by 98.51% to $43.1 million in 2026.
  • Per Business Quant, the three most recent readings for SNPS's Cash & Equivalents are $43.1 million (Q1 2026), $2.9 billion (Q4 2025), and $2.6 billion (Q3 2025).